C-Src-mediated RANKL-induced breast cancer cell migration by activation of the ERK and Akt pathway.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Oncology Letters

• Publication date

  2012-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/OL.2011.487PMID 22740919PMCID PMC3362513
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Receptor Activator of NF-kB (RANK) Expression in Primary Tumors Associates with Bone Metastasis Occurrence in Breast Cancer Patients

  2011cited by this paper
• Suppression of EGF-induced tumor cell migration and matrix metalloproteinase-9 expression by capsaicin via the inhibition of EGFR-mediated FAK/Akt, PKC/Raf/ERK, p38 MAPK, and AP-1 signaling.

  2011cited by this paper
• Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study.

  2011cited by this paper
• RANKL increases migration of human lung cancer cells through intercellular adhesion molecule‐1 up‐regulation

  2011influential reference
• Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases

  2011influential reference
• Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells

  2010cited by this paper
• SRC kinase inhibition: targeting bone metastases and tumor growth in prostate and breast cancer.

  2010cited by this paper
• Future directions of bone-targeted therapy for metastatic breast cancer

  2010cited by this paper
• Advances in Targeting Src in the Treatment of Breast Cancer and Other Solid Malignancies

  2010cited by this paper
• Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study.

  2010cited by this paper
• Cancer Statistics, 2010

  2010cited by this paper
• Shedding of RANKL by tumor-associated MT1-MMP activates Src-dependent prostate cancer cell migration.

  2010influential reference
• Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas

  2009influential reference
• Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion

  2009cited by this paper
• Latent bone metastasis in breast cancer tied to Src-dependent survival signals.

  2009cited by this paper
• Targeting Src signaling in metastatic bone disease

  2009cited by this paper
• Low-risk susceptibility alleles in 40 human breast cancer cell lines

  2009cited by this paper
• RANKL acts directly on RANK‐expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes

  2008cited by this paper
• The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expression

  2007cited by this paper
• Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases.

  2007cited by this paper
• Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells

  2007cited by this paper
• Denosumab in postmenopausal women with low bone mineral density.

  2006cited by this paper
• Denosumab in postmenopausal women with low bone mineral density.

  2006cited by this paper
• Cell-Based Assay Strategy for Identification of Motif-Specific RANK Signaling Pathway Inhibitors

  2006influential reference
• EGF-Induced Cell Migration Is Mediated by ERK and PI3K/AKT Pathways in Cultured Human Lens Epithelial Cells

  2006cited by this paper
• Regulation of cancer cell migration and bone metastasis by RANKL

  2006influential reference
• Mechanisms of bone metastasis.

  2004influential reference
• Mechanisms of bone metastasis.

  2004cited by this paper
• Src family kinases in tumor progression and metastasis

  2003cited by this paper
• C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis.

  2003cited by this paper
• The role of osteoclastic activity in prostate cancer skeletal metastases.

  2002cited by this paper
• Involvement of chemokine receptors in breast cancer metastasis

  2001cited by this paper
• The role of chemoattraction in cancer metastases.

  2001cited by this paper
• Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif.

  1999influential reference
• Breast cancer cells interact with osteoblasts to support osteoclast formation.

  1999cited by this paper
• Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.

  1999cited by this paper
• Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

  1998cited by this paper
• Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

  1998cited by this paper
• RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis.

  1998cited by this paper
• Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase.

  1998cited by this paper
• Characterization of the Intracellular Domain of Receptor Activator of NF-κB (RANK)

  1998cited by this paper
• TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival.

  1997influential reference
• Printed in U.S.A. Copyright © 1999 by The Endocrine Society Breast Cancer Cells Interact with Osteoblasts to Support

  year unknowncited by this paper

• RANKL Drives Bone Metastasis in Mammary Cancer: Protective Effects of Anti-Resorptive Treatments

  2025cites this paper
• RANKL regulates differentially breast cancer stem cell properties through its RANK and LGR4 receptors.

  2024cites this paper
• Revisiting the CXCL13/CXCR5 Axis in the Tumor Microenvironment in the Era of Single-cell Omics: Implications for Immunotherapy.

  2024cites this paper
• Long-Term Survival in Human Epidermal Growth Factor Receptor 2-Positive Bone-Only Metastatic Breast Cancer: Trastuzumab, Denosumab, and Potential Synergistic Effects

  2024cites this paper
• Obacunone inhibits RANKL/M-CSF-mediated osteoclastogenesis by suppressing integrin- FAK-Src signaling.

  2023cites this paper
• c-Src inhibitor PP2 inhibits head and neck cancer progression through regulation of the epithelial–mesenchymal transition

  2022cites this paper
• RANKL biology.

  2022cites this paper
• Biomarker LEPRE1 induces pelitinib-specific drug responsiveness by regulating ABCG2 expression and tumor transition states in human leukemia and lung cancer

  2022cites this paper
• Role of RANKL in cancer development and metastasis

  2021cites this paper
• RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer

  2021cites this paper
• Knockdown of AKT3 Activates HER2 and DDR Kinases in Bone-Seeking Breast Cancer Cells, Promotes Metastasis In Vivo and Attenuates the TGFβ/CTGF Axis

  2021cites this paper
• CXCL13 in Cancer and Other Diseases: Biological Functions, Clinical Significance, and Therapeutic Opportunities

  2021cites this paper
• CXCL13 Signaling in the Tumor Microenvironment.

  2021cites this paper
• Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast Cancer

  2020cites this paper
• How Different Are the Molecular Mechanisms of Nodal and Distant Metastasis in Luminal A Breast Cancer?

  2020cites this paper
• LINC00461 promotes cell migration and invasion in breast cancer through miR‐30a‐5p/integrin β3 axis

  2019cites this paper
• Soluble RANKL is physiologically dispensable but accelerates tumour metastasis to bone

  2019cites this paper
• Soluble RANKL is physiologically dispensable but accelerates tumour metastasis to bone

  2019cites this paper
• CXCL13/CXCR5 signaling axis in cancer.

  2019cites this paper
• Efficacy of an orally active small-molecule inhibitor of RANKL in bone metastasis

  2019cites this paper
• Caveolin-1 enhances RANKL-induced gastric cancer cell migration

  2018cites this paper
• The E3 ligase C-CBL inhibits cancer cell migration by neddylating the proto-oncogene c-Src

  2018cites this paper
• Breast cancer bone metastases: pathogenesis and therapeutic targets.

  2018cites this paper
• Sphingosine‐1‐phosphate suppresses chondrosarcoma metastasis by upregulation of tissue inhibitor of metalloproteinase 3 through suppressing miR‐101 expression

  2017cites this paper
• Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis

  2017cites this paper
• Fusaric acid (FA) protects heart failure induced by isoproterenol (ISP) in mice through fibrosis prevention via TGF-β1/SMADs and PI3K/AKT signaling pathways.

  2017cites this paper
• RANKL/RANK pathway abrogates cetuximab sensitivity in gastric cancer cells via activation of EGFR and c-Src

  2017cites this paper
• PRL-3 engages the focal adhesion pathway in triple-negative breast cancer cells to alter actin structure and substrate adhesion properties critical for cell migration and invasion.

  2016cites this paper
• Stiffened Extracellular Matrix and Signaling from Stromal Fibroblasts via Osteoprotegerin Regulate Tumor Cell Invasion in a 3-D Tumor in Situ Model

  2016cites this paper
• RANKL Signaling and ErbB Receptors in Breast Carcinogenesis.

  2016cites this paper
• Erratum to: CXCL13–CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis

  2016cites this paper
• The RANK Pathway in Advanced Breast Cancer: Does Src Play a Role?

  2016cites this paper
• The E3 ubiquitin ligase Cbl-b improves the prognosis of RANK positive breast cancer patients by inhibiting RANKL-induced cell migration and metastasis

  2015cites this paper
• 20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol, a metabolite of ginsenoside Rb1, enhances the production of hyaluronic acid through the activation of ERK and Akt mediated by Src tyrosin kinase in human keratinocytes.

  2015cites this paper
• Prostate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristics

  2015cites this paper
• Breast Cancer Cell Colonization of the Human Bone Marrow Adipose Tissue Niche1

  2015cites this paper
• MPA influences tumor cell proliferation, migration, and invasion induced by RANKL through PRB involving the MAPK pathway in endometrial cancer.

  2015cites this paper
• Mathematical Modelling of Molecular Pathways Enabling Tumour Cell Invasion and Migration

  2015cites this paper
• Fhit Regulates EMT Targets through an EGFR/Src/ERK/Slug Signaling Axis in Human Bronchial Cells

  2014cites this paper
• BMP9 regulates cross-talk between breast cancer cells and bone marrow-derived mesenchymal stem cells

  2014cites this paper
• Targeting RANKL in metastasis

  2014cites this paper
• RANKL/RANK/MMP-1 Molecular Triad Contributes to the Metastatic Phenotype of Breast and Prostate Cancer Cells In Vitro

  2013cites this paper
• Chlamydia pneumoniae Infection Promotes Vascular Smooth Muscle Cell Migration through a Toll-Like Receptor 2-Related Signaling Pathway

  2013cites this paper
• Age-related effects on the mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in breast cancer and the characterization of novel MEK5 inhibitors

  2013cites this paper
• CXCL13–CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis

  2013cites this paper
• Expression of DNMTs and genomic DNA methylation in gastric signet ring cell carcinoma.

  2013cites this paper
• RANKL enhances the effect of an antagonist of inhibitor of apoptosis proteins (cIAPs) in RANK-positive breast cancer cells

  2013cites this paper
• The Interaction of Adrenomedullin and Macrophages Induces Ovarian Cancer Cell Migration via Activation of RhoA Signaling Pathway

  2013cites this paper
• La trans-sialidasa como factor de virulencia en la infección experimental con Trypanosoma cruzi

  2012cites this paper
• 抑制Src酪氨酸激酶活性对人肺癌A549/DDP细胞耐药性及MDR1和LRP表达的影响

  2012cites this paper